Biolargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
March 30, 2021 at 09:45 pm
Share
BioLargo, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was USD 2.432 million compared to USD 1.861 million a year ago. Operating loss was USD 7.583 million compared to USD 6.696 million a year ago. Net loss was USD 8.432 million compared to USD 10.690 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.08 a year ago.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.